EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Nuclear receptor 4A1 (NR4A1) upregulated by n ‐butylidenephthalide via the mitogen‐activated protein kinase ( MAPK) pathway ameliorates drug‐induced gingival enlargement

Tomoya Ueda, Shinji Matsuda iD, Yurika Ninomiya, Fuminori Nakashima, Keisuke Yasuda, Daisuke Furutama, Takumi Memida, Tetsuya Yoshimoto, Mikihito Kajiya, Kouji Ohta, Kazuhisa Ouhara, Noriyoshi Mizuno

BioFactors · 2024-11 · 50 (6) · 1192-1207

DOI: 10.1002/biof.2077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioFactors, online erschienen am 22.05.2024. Verfasst von Tomoya Ueda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 4, Group A, Member 1, Phthalic Anhydrides, MAP Kinase Signaling System, Fibroblasts. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug‐induced gingival enlargement (DIGE) is a side effect of ciclosporin, calcium channel blockers, and phenytoin. DIGE is a serious disease that leads to masticatory and esthetic disorders, severe caries, and periodontitis but currently has no standard treatment. We recently reported that nuclear receptor 4A1 (NR4A1) is a potential therapeutic target for DIGE. This study aimed to evaluate the therapeutic effects of n ‐butylidenephthalide (BP), which increases the expression of NR4A1, on DIGE. In this study, NR4A1 mRNA expression was analyzed in the patients with periodontal disease (PD) and DIGE. We evaluated the effect of BP on NR4A1 expression in gingival fibroblasts and in a DIGE mouse model. RNA sequencing (RNA‐seq) was conducted to identify the mechanisms by which BP increases NR4A1 expression. The results showed that NR4A1 mRNA expression in the patients with DIGE was significantly lower than the patients with PD. BP suppressed the upregulation of COL1A1 expression, which was upregulated by TGF‐β. BP also ameliorated gingival overgrowth in DIGE mice and reduced Col1a1 and Pai1 expression. BP also decreased Il1β mRNA expression in gingival tissue in DIGE. RNA‐seq results showed an increase in the expression of several genes related to mitogen‐activated protein kinase including DUSP genes in gingival fibroblasts stimulated by BP. Treatment with ERK and JNK inhibitors suppressed the BP‐induced increase in NR4A1 expression. In addition, BP promoted the phosphorylation of ERK in gingival fibroblasts. In conclusion, BP increases NR4A1 expression in gingival fibroblasts through ERK and JNK signaling, demonstrating its potential as a preventive and therapeutic agent against DIGE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Receptor Subfamily 4, Group A, Member 1Phthalic AnhydridesMAP Kinase Signaling SystemFibroblastsGingivaAnimalsMiceHumansMaleGingival OvergrowthUp-RegulationInterleukin-1betaFemaleCyclosporineDisease Models, AnimalMice, Inbred C57BLPhenytoin

Stichwörter der Autor:innen

COL1A1ERKMAPKNR4A1drug‐induced gingival enlargementn‐butylidenephthalide

Substanzen

Nuclear Receptor Subfamily 4, Group A, Member 1butylidenephthalidePhthalic AnhydridesNr4a1 protein, mouseNR4A1 protein, humanInterleukin-1betaCyclosporinePhenytoin

Autor:innen und Institutionen

  • Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Biological Endodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Oral Science and Translation Research, College of Dental Medicine, Nova Southeastern University, Fort Lauderdale, Florida, USA.
  • Center of Oral Clinical Examination, Hiroshima University Hospital, Hiroshima, Japan.
  • Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

ORCID-Profile: Shinji Matsuda

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency

Zitieren

APA

Ueda, T., Matsuda, S., Ninomiya, Y., Nakashima, F., Yasuda, K., Furutama, D., Memida, T., Yoshimoto, T., Kajiya, M., Ohta, K., Ouhara, K., & Mizuno, N. (2024). Nuclear receptor 4A1 (NR4A1) upregulated by n ‐butylidenephthalide via the mitogen‐activated protein kinase ( MAPK) pathway ameliorates drug‐induced gingival enlargement. BioFactors, 50(6), 1192-1207. https://doi.org/10.1002/biof.2077

Vancouver

Ueda T, Matsuda S, Ninomiya Y, Nakashima F, Yasuda K, Furutama D, et al. Nuclear receptor 4A1 (NR4A1) upregulated by n ‐butylidenephthalide via the mitogen‐activated protein kinase ( MAPK) pathway ameliorates drug‐induced gingival enlargement. BioFactors. 2024;50(6):1192-1207. doi:10.1002/biof.2077

BibTeX
@article{Ueda2024,
  author = {Ueda, Tomoya and Matsuda, Shinji and Ninomiya, Yurika and Nakashima, Fuminori and Yasuda, Keisuke and Furutama, Daisuke and Memida, Takumi and Yoshimoto, Tetsuya and Kajiya, Mikihito and Ohta, Kouji and Ouhara, Kazuhisa and Mizuno, Noriyoshi},
  title = {Nuclear receptor 4A1 (NR4A1) upregulated by n ‐butylidenephthalide via the mitogen‐activated protein kinase ( MAPK) pathway ameliorates drug‐induced gingival enlargement},
  journal = {BioFactors},
  year = {2024},
  volume = {50},
  number = {6},
  pages = {1192--1207},
  doi = {10.1002/biof.2077}
}
Kostenlos starten →